Global Blood Therapeutics, Inc.·4

Mar 3, 8:00 PM ET

CATHERS BRIAN EDWIN 4

4 · Global Blood Therapeutics, Inc. · Filed Mar 3, 2021

Insider Transaction Report

Form 4
Period: 2021-03-01
Transactions
  • Award

    Restricted Stock Units

    2021-03-01+17,73317,733 total
    Common Stock (17,733 underlying)
  • Tax Payment

    Common Stock

    2021-03-01$44.48/sh1,297$57,69112,005 total
  • Award

    Stock Option (Right to Buy)

    2021-03-01+31,08231,082 total
    Exercise: $44.48Exp: 2031-02-28Common Stock (31,082 underlying)
  • Exercise/Conversion

    Common Stock

    2021-03-01+3,75013,302 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-03-013,75015,000 total
    Common Stock (3,750 underlying)
Footnotes (5)
  • [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
  • [F2]Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 3,750 shares of Common Stock underlying the Reporting Person's RSUs.
  • [F3]The shares of Common Stock underlying the RSUs vested with respect to 1/4th of the shares on March 1, 2020 and thereafter 1/6th of the remaining underlying shares shall vest in semi-annual installments over 3 years from March 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
  • [F4]The shares of Common Stock underlying the option vest in 16 equal quarterly installments over 4 years from March 1, 2021, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
  • [F5]The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2021, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION